AttenGluco: Multimodal Transformer-Based Blood Glucose Forecasting on AI-READI Dataset

• URL: http://arxiv.org/abs/2502.09919v1
• Date: Fri, 14 Feb 2025 05:07:38 GMT
• Title: AttenGluco: Multimodal Transformer-Based Blood Glucose Forecasting on AI-READI Dataset
• Authors: Ebrahim Farahmand, Reza Rahimi Azghan, Nooshin Taheri Chatrudi, Eric Kim, Gautham Krishna Gudur, Edison Thomaz, Giulia Pedrielli, Pavan Turaga, Hassan Ghasemzadeh,
• Abstract summary: Diabetes is a chronic metabolic disorder characterized by persistently high blood glucose levels (BGLs) Recent deep learning models show promise in improving BGL prediction. We propose AttenGluco, a multimodal Transformer-based framework for long-term blood glucose prediction.
• Score: 8.063401183752347
• License:
• Abstract: Diabetes is a chronic metabolic disorder characterized by persistently high blood glucose levels (BGLs), leading to severe complications such as cardiovascular disease, neuropathy, and retinopathy. Predicting BGLs enables patients to maintain glucose levels within a safe range and allows caregivers to take proactive measures through lifestyle modifications. Continuous Glucose Monitoring (CGM) systems provide real-time tracking, offering a valuable tool for monitoring BGLs. However, accurately forecasting BGLs remains challenging due to fluctuations due to physical activity, diet, and other factors. Recent deep learning models show promise in improving BGL prediction. Nonetheless, forecasting BGLs accurately from multimodal, irregularly sampled data over long prediction horizons remains a challenging research problem. In this paper, we propose AttenGluco, a multimodal Transformer-based framework for long-term blood glucose prediction. AttenGluco employs cross-attention to effectively integrate CGM and activity data, addressing challenges in fusing data with different sampling rates. Moreover, it employs multi-scale attention to capture long-term dependencies in temporal data, enhancing forecasting accuracy. To evaluate the performance of AttenGluco, we conduct forecasting experiments on the recently released AIREADI dataset, analyzing its predictive accuracy across different subject cohorts including healthy individuals, people with prediabetes, and those with type 2 diabetes. Furthermore, we investigate its performance improvements and forgetting behavior as new cohorts are introduced. Our evaluations show that AttenGluco improves all error metrics, such as root mean square error (RMSE), mean absolute error (MAE), and correlation, compared to the multimodal LSTM model. AttenGluco outperforms this baseline model by about 10% and 15% in terms of RMSE and MAE, respectively.

Related papers

• Hybrid Attention Model Using Feature Decomposition and Knowledge Distillation for Glucose Forecasting [6.466206145151128]
  GlucoNet is an AI-powered sensor system for continuously monitoring behavioral and physiological health. We propose a decomposition-based transformer model that incorporates patients' behavioral and physiological data. G GlucoNet achieves a 60% improvement in RMSE and a 21% reduction in the number of parameters, using data obtained involving 12 participants with T1-Diabetes.
  arXiv  Detail & Related papers  (2024-11-16T05:09:20Z)
• FedGlu: A personalized federated learning-based glucose forecasting algorithm for improved performance in glycemic excursion regions [4.073768455373616]
  Continuous glucose monitoring (CGM) devices provide real-time glucose monitoring and timely alerts for glycemic excursions. Rare events like hypoglycemia and hyperglycemia remain challenging due to their infrequency. We propose a novel Hypo-Hyper (HH) loss function, which significantly improves performance in the glycemic excursion regions.
  arXiv  Detail & Related papers  (2024-08-25T19:51:27Z)
• From Glucose Patterns to Health Outcomes: A Generalizable Foundation Model for Continuous Glucose Monitor Data Analysis [47.23780364438969]
  We present GluFormer, a generative foundation model for CGM data that learns nuanced glycemic patterns and translates them into predictive representations of metabolic health. GluFormer generalizes to 19 external cohorts spanning different ethnicities and ages, 5 countries, 8 CGM devices, and diverse pathophysiological states. In a longitudinal study of 580 adults with CGM data and 12-year follow-up, GluFormer identifies individuals at elevated risk of developing diabetes more effectively than blood HbA1C%.
  arXiv  Detail & Related papers  (2024-08-20T13:19:06Z)
• Using Pre-training and Interaction Modeling for ancestry-specific disease prediction in UK Biobank [69.90493129893112]
  Recent genome-wide association studies (GWAS) have uncovered the genetic basis of complex traits, but show an under-representation of non-European descent individuals. Here, we assess whether we can improve disease prediction across diverse ancestries using multiomic data.
  arXiv  Detail & Related papers  (2024-04-26T16:39:50Z)
• Toward Short-Term Glucose Prediction Solely Based on CGM Time Series [4.7066018521459725]
  TimeGlu is an end-to-end pipeline for short-term glucose prediction based on CGM time series data. It achieves state-of-the-art performance without the need for additional personal data from patients.
  arXiv  Detail & Related papers  (2024-04-18T06:02:12Z)
• GARNN: An Interpretable Graph Attentive Recurrent Neural Network for Predicting Blood Glucose Levels via Multivariate Time Series [12.618792803757714]
  We propose interpretable graph attentive neural networks (GARNNs) to model multi-modal data. GARNNs achieve the best prediction accuracy and provide high-quality temporal interpretability. These findings underline the potential of GARNN as a robust tool for improving diabetes care.
  arXiv  Detail & Related papers  (2024-02-26T01:18:53Z)
• Machine Learning based prediction of Glucose Levels in Type 1 Diabetes Patients with the use of Continuous Glucose Monitoring Data [0.0]
  Continuous Glucose Monitoring (CGM) devices offer detailed, non-intrusive and real time insights into a patient's blood glucose concentrations. Leveraging advanced Machine Learning (ML) Models as methods of prediction of future glucose levels, gives rise to substantial quality of life improvements.
  arXiv  Detail & Related papers  (2023-02-24T19:10:40Z)
• SurvLatent ODE : A Neural ODE based time-to-event model with competing risks for longitudinal data improves cancer-associated Deep Vein Thrombosis (DVT) prediction [68.8204255655161]
  We propose a generative time-to-event model, SurvLatent ODE, which parameterizes a latent representation under irregularly sampled data. Our model then utilizes the latent representation to flexibly estimate survival times for multiple competing events without specifying shapes of event-specific hazard function. SurvLatent ODE outperforms the current clinical standard Khorana Risk scores for stratifying DVT risk groups.
  arXiv  Detail & Related papers  (2022-04-20T17:28:08Z)
• Label scarcity in biomedicine: Data-rich latent factor discovery enhances phenotype prediction [102.23901690661916]
  Low-dimensional embedding spaces can be derived from the UK Biobank population dataset to enhance data-scarce prediction of health indicators, lifestyle and demographic characteristics. Performances gains from semisupervison approaches will probably become an important ingredient for various medical data science applications.
  arXiv  Detail & Related papers  (2021-10-12T16:25:50Z)
• Predicting Parkinson's Disease with Multimodal Irregularly Collected Longitudinal Smartphone Data [75.23250968928578]
  Parkinsons Disease is a neurological disorder and prevalent in elderly people. Traditional ways to diagnose the disease rely on in-person subjective clinical evaluations on the quality of a set of activity tests. We propose a novel time-series based approach to predicting Parkinson's Disease with raw activity test data collected by smartphones in the wild.
  arXiv  Detail & Related papers  (2020-09-25T01:50:15Z)
• Short Term Blood Glucose Prediction based on Continuous Glucose Monitoring Data [53.01543207478818]
  This study explores the use of Continuous Glucose Monitoring (CGM) data as input for digital decision support tools. We investigate how Recurrent Neural Networks (RNNs) can be used for Short Term Blood Glucose (STBG) prediction.
  arXiv  Detail & Related papers  (2020-02-06T16:39:44Z)

This list is automatically generated from the titles and abstracts of the papers in this site.

This site does not guarantee the quality of this site (including all information) and is not responsible for any consequences.